To elucidate the potential role of NGAL in the pathogenesis of GDM and the development of the fetus, we examined its plasma levels in maternal blood and umbilical cord blood and its expression levels in placental and umbilical cord tissues in women with GDM and women with normal pregnancies. This evidence concerns the gene LCN2 and gestational diabetes.